Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Status:
NOT_YET_RECRUITING
Trial end date:
2032-12-31
Target enrollment:
Participant gender:
Summary
This study is a multicenter randomized controlled trial conducted in Korea. A parallel, two-group randomized design will be with thyroid stimulating hormone suppression therapy group(low TSH group; intervention) is different from the wIthout thyroid stimulating hormone (TSH) suppression therapy group(high TSH group; control).
Phase:
NA
Details
Lead Sponsor:
National Cancer Center, Korea
Collaborators:
Seoul National University Bundang Hospital Seoul National University Hospital